Salesforce, Inc. (NYSE: CRM) ended Wednesday, December 17, 2025, on a relative high in a tough tape—then edged lower in after-hours trading as investors processed late-day headlines and looked ahead to a potentially market-moving inflation print Thursday morning.
Salesforce stock price after the bell: where CRM stands tonight
In regular NYSE trading, Salesforce closed at $258.14, up about 1.27% on the day. In after-hours trading, the stock slipped to roughly $257.50 (down ~0.25%) as of around 6:15 p.m. ET.
Wednesday’s session showed a wide—but controlled—trading range for CRM: $256.37 (low) to $261.97 (high), with the stock opening near $256.33.
That small after-hours dip matters less than why CRM outperformed during the day—and what could reset sentiment before the opening bell on Thursday, December 18, 2025.
The two Salesforce headlines that mattered most today
1) Novartis expands with Salesforce: Agentforce Life Sciences goes global
Salesforce announced that Novartis selected “Agentforce Life Sciences for Customer Engagement”, aiming to unify customer engagement across teams such as marketing, sales, patient services, medical, and market access. The rollout is expected to occur globally over the next five years and builds on Novartis’ prior Salesforce investments (including Agentforce Health, Data 360 for Health & Life Sciences, MuleSoft for Life Sciences, and Agentforce Marketing). Salesforce+1
Why markets care: large enterprise and regulated-industry deployments are exactly the kind of “proof points” investors want to see as Salesforce pushes its Agentforce strategy from pilots into scaled production.
A Reuters/Refinitiv item also summarized the key points: Novartis selecting Agentforce for customer engagement and planning a five-year global rollout of Agentforce 360.
2) Salesforce agrees to acquire Qualified (agentic AI marketing)
After the close, Salesforce announced it signed a definitive agreement to acquire Qualified, describing it as a leading provider of agentic AI marketing—including an “always-on” AI worker designed to engage inbound buyers and convert website traffic into pipeline.
Salesforce explicitly tied the deal to accelerating Agentforce (especially Agentforce Sales and Agentforce Marketing). The company also said the transaction is expected to close in Q1 of Salesforce’s fiscal year 2027, subject to customary conditions and regulatory approvals (with financial terms not disclosed in the announcement).
Why it may have nudged CRM lower after hours: acquisitions—especially with undisclosed terms—often trigger a “wait for details” reaction, even when the strategic logic is clear. Traders may also be reluctant to take big positions into Thursday’s inflation report.
Today’s biggest Wall Street “forecast” on Salesforce: BTIG’s new Buy call
A key piece of fresh sell-side coverage hit today: BTIG initiated Salesforce with a Buy rating and a $335 price target. In that note, BTIG pointed to Salesforce’s platform re-architecture, Data 360 positioning, and rapid Agentforce innovation.
BTIG also highlighted metrics around Agentforce traction, including commentary that Agentforce ARR reached $540 million (up 330% year over year) and discussed differences between pilot customers and production deployments—while forecasting a return to double-digit subscription growth later in the cycle.
In the same write-up, InvestingPro-based data cited a broadly constructive Street setup: a “strong buy” consensus rating (1.64) and a wide target range ($223 to $475)—a reminder that expectations (and dispersion) remain high. Investing.com
A separate market recap also tied Salesforce’s strength today to a combination of the Novartis news and the BTIG initiation.
Why Salesforce outperformed even as tech sold off
CRM’s relative strength stood out because the broader market weakened into the close. By end-of-day Wednesday, major indexes were lower, with the Dow down ~0.47%, the S&P 500 down ~1.16%, and the Nasdaq down ~1.81%.
The key driver of the broader risk-off mood was renewed anxiety around AI infrastructure spending and funding, catalyzed by an Oracle-related headline: Reuters reported Oracle’s $10 billion Michigan data center project faced uncertainty after Blue Owl withdrew as the main financial backer.
In that context, Salesforce’s move looked more company-specific than macro-driven: investors had tangible news (Novartis) and a fresh bullish initiation (BTIG) to lean on, while other AI-linked names were trading on macro fears.
What to know before the market opens tomorrow (Thursday, Dec. 18, 2025)
Here’s the actionable premarket checklist for CRM holders and watchers.
1) Salesforce goes ex-dividend tomorrow — don’t misread the open
CRM is scheduled to trade ex-dividend on December 18, 2025, tied to Salesforce’s quarterly cash dividend of $0.416 per share.
Salesforce previously announced the dividend is payable January 8, 2026, to shareholders of record on December 18, 2025.
What this means in plain English:
- If you buy CRM on Dec. 18, you typically won’t receive this dividend.
- It’s common for a stock to appear to “gap down” by roughly the dividend amount on the ex-date—even if nothing fundamental changed overnight.
- So if CRM opens lower on Thursday, separate the mechanical dividend effect from any true change in sentiment.
2) 8:30 a.m. ET is the big macro moment: U.S. CPI hits before the bell
Thursday morning brings a major risk event for all equities—especially mega-cap tech and software multiples:
- The Bureau of Labor Statistics schedule shows the November 2025 CPI release is set for December 18, 2025 at 8:30 a.m. ET.
- BLS also noted revisions related to the 2025 lapse in appropriations and confirmed publication timing for the November 2025 CPI report.
Markets typically react quickly to CPI surprises through rates and index futures. For a name like Salesforce—often valued on forward growth and margin narratives—CPI-driven moves in yields can matter as much as company news in the short run.
3) Also at 8:30 a.m. ET: weekly jobless claims (and other data)
Alongside CPI, initial jobless claims are also on the Thursday calendar.
If CPI is “hot” and labor data looks resilient, traders may price a more restrictive rate path—often a headwind for growth/software. If CPI cools or labor data weakens, it can support a relief move (or at least stabilize multiples).
4) Watch for follow-on details and analyst notes on the Qualified deal
The acquisition headline is now out, but the market typically looks for:
- Integration details (how quickly Qualified features show up inside Agentforce/Marketing Cloud workflows)
- Any talk of near-term dilution vs. acceleration in pipeline conversion
- Regulatory timing and closing conditions (Salesforce flagged required approvals)
If more firms publish quick-take research Thursday morning, that can drive premarket price discovery—especially because the initial after-hours move was modest.
5) Near-term price levels traders will likely reference
If you’re watching levels rather than long-term fundamentals, Wednesday gave clean markers:
- Resistance reference: the day’s high near $261.97
- Support reference: the day’s low near $256.37
- After-hours reference: about $257.50 at ~6:15 p.m. ET
A CPI-driven futures swing can overwhelm these levels, but they tend to be the first “checkpoints” traders use to judge whether a move is real.
Bottom line: CRM has catalysts, but the opening may be macro-driven
Salesforce delivered two AI-forward headlines today (Novartis adopting Agentforce Life Sciences and the Qualified acquisition) and picked up a new Buy initiation with a $335 target—helping CRM outperform into the close.
But between the ex-dividend date (Dec. 18) and CPI at 8:30 a.m. ET, Thursday’s open has the potential to look “messy” even if the underlying story hasn’t changed. StockAnalysis+1
